{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:49:54Z","timestamp":1753876194387,"version":"3.41.2"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013845","name":"Foundation Against Cancer","doi-asserted-by":"publisher","award":["2021\/1594","2023\/034"],"award-info":[{"award-number":["2021\/1594","2023\/034"]}],"id":[{"id":"10.13039\/501100013845","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Disseminated Aspergillus infection is a severe condition in immunocompromised patients. Mortality secondary to cardiac Aspergillus infection remains high.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>We present a case of a 45-year-old female breast cancer patient who developed Aspergillus fumigatus endocarditis and myocarditis after receiving the immune checkpoint inhibitor (ICI) pembrolizumab. The infection emerged as a complication following the management of a severe immune-related adverse event (irAE) with high doses of immunosuppressants, triggered by the ICI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>The use of ICIs and the subsequent treatment of irAEs with immunosuppressants introduce a new subset of immunocompromised patients at risk for fungal infections. While alternative corticosteroid-sparing immune-modulating agents such as biologicals, intravenous immunoglobulins, and disease-modifying anti-rheumatic drugs have been explored, there is lack of prospective studies evaluating their efficacy and safety in this context.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytaf058","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T07:42:51Z","timestamp":1738654971000},"source":"Crossref","is-referenced-by-count":1,"title":["Endo- and myocarditis as a severe complication of immune-related adverse event treatment: a case report"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3896-8116","authenticated-orcid":false,"given":"Lauren","family":"Van den Bosch","sequence":"first","affiliation":[{"name":"Department of Cardiology, Antwerp University Hospital , Drie Eikenstraat 655, 2650 Edegem ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PieterJan","family":"Vanclooster","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Antwerp University Hospital , Drie Eikenstraat 655, 2650 Edegem ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2458-742X","authenticated-orcid":false,"given":"Jan","family":"Van Offenwert","sequence":"additional","affiliation":[{"name":"Department of Radiology, Antwerp University Hospital , Drie Eikenstraat 655, 2650 Edegem ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure-Anne","family":"Teuwen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Antwerp University Hospital , Drie Eikenstraat 655, 2650 Edegem ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7085-5317","authenticated-orcid":false,"given":"Constantijn","family":"Franssen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Antwerp University Hospital , Drie Eikenstraat 655, 2650 Edegem ,","place":["Belgium"]},{"name":"Research Group Cardiovascular Diseases, University of Antwerp , Wilrijkstraat 10, 2650 Edegem ,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"2025030711464578200_ytaf058-B1","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaccao.2022.11.005","article-title":"Immune checkpoint inhibitor myocarditis treatment strategies and future directions","volume":"4","author":"Moslehi","year":"2022","journal-title":"JACC CardioOncol"},{"key":"2025030711464578200_ytaf058-B2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fonc.2018.00086","article-title":"Anti-PD-1 and anti-CTLA-4 therapies in cancer: mechanisms of action, efficacy, and limitations","volume":"8","author":"Seidel","year":"2018","journal-title":"Front Oncol"},{"key":"2025030711464578200_ytaf058-B3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-020-0160-6","article-title":"Immune-related adverse events of checkpoint inhibitors","volume":"6","author":"Ramos-Casals","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2025030711464578200_ytaf058-B4","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann Oncol"},{"key":"2025030711464578200_ytaf058-B5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/myc.13415","article-title":"Aspergillus endocarditis in the recent years, report of cases of a multicentric national cohort and literature review","volume":"65","author":"Valerio","year":"2022","journal-title":"Mycoses"},{"key":"2025030711464578200_ytaf058-B6","doi-asserted-by":"crossref","first-page":"e00567","DOI":"10.1016\/j.idcr.2019.e00567","article-title":"Aspergillosis myocarditis in the immunocompromised host","volume":"17","author":"Bullis","year":"2019","journal-title":"IDCases"},{"key":"2025030711464578200_ytaf058-B7","first-page":"418357","article-title":"Isolated aspergillosis myocardial abscesses in a liver-transplant patient","volume":"2014","author":"Dang-Tran","year":"2014","journal-title":"Case Rep Transplant"},{"key":"2025030711464578200_ytaf058-B8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.5858\/2005-129-511-CAIPWA","article-title":"Cardiac aspergillosis in patients with acquired immunodeficiency syndrome: a case report and review of the literature","volume":"129","author":"Xie","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"2025030711464578200_ytaf058-B9","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1001\/archinte.1987.00370110070010","article-title":"Isolated cardiac aspergillosis after bone marrow transplantation","volume":"147","author":"Johnson","year":"1987","journal-title":"Arch Intern Med"},{"key":"2025030711464578200_ytaf058-B10","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2025030711464578200_ytaf058-B11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1634\/theoncologist.2018-0130","article-title":"Immune checkpoint inhibitor-associated myocarditis","volume":"23","author":"Ganatra","year":"2018","journal-title":"Oncologist"},{"key":"2025030711464578200_ytaf058-B12","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"JCO"},{"key":"2025030711464578200_ytaf058-B13","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"2025030711464578200_ytaf058-B14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.healun.2016.01.007","article-title":"The 2015 International Society for Heart and Lung Transplantation guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: executive summary","volume":"35","author":"Husain","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2025030711464578200_ytaf058-B15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytaf058\/61745669\/ytaf058.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/3\/ytaf058\/61745669\/ytaf058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/3\/ytaf058\/61745669\/ytaf058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T11:47:37Z","timestamp":1741348057000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytaf058\/7997875"}},"subtitle":[],"editor":[{"given":"Giacomo Tini","family":"Melato","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Jon Zubiaur","family":"Zamacola","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Shahrukh","family":"Hashmani","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Maria Isabel Gonzalez","family":"Del Hoyo","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytaf058","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,2,4]]},"article-number":"ytaf058"}}